Searched for
JUBILANT PHARMOVA STOCK
Jubilant Pharmova shares decline 6% after Q1 profits falls 45% YoYJubilant Pharmova shares fell after Q1 profit plunged 45% YoY to Rs 56 crore, despite revenue rising 17% to Rs 2,229 crore. The profit decl...- Jubilant Pharmova among 4 stocks flashing bullish signals, hinting at a possible uptrendFour Nifty500 stocks featured in StockEdge’s White Marubozu scan on August 10, signalling strong buying pressure. Syrma SGS, Cemindia Proje...
- Avenue Supermarts among 4 stocks showing bullish RSI upswingOn August 10, four Nifty500 stocks showed strengthening RSI momentum after crossing above 50, signalling potential upward movement. Avenue ...
- Q1 Results Tracker: Tata Motors, Vodafone Idea among 2,045 companies set to announce earnings this weekGoldman Sachs expects the Nifty 50 to rebound to 26,500 by June 2027, above its current record high, as India’s macro backdrop improves. Lo...
- Dividend alert! Last day to buy Bharti Airtel, Hero MotoCorp, among 43 stocks for dividend payout worth Rs 1,127As per Sebi's T+1 settlement cycle, investors must buy a company's shares at least one trading day before the record date to ensure the sha...
- Bonus, dividends and stock splits: Bharti Airtel, Hero MotoCorp among 88 stocks turning ex-date this week. Do you own any?Investors must hold shares in their demat accounts on the respective record dates to be eligible. Here is the complete day-wise list of key...
- Ahead of Market: 10 things that will decide stock market action on ThursdayIndian equities ended marginally higher after surrendering most intraday gains. Softer US inflation data supported sentiment, while elevate...
- Stocks in news: Bajaj Finance, Kronox Lab, IDBI Bank, Dr Reddy's, Godawari Power, Jubilant PharmovaDomestic markets navigated a volatile week, ending near all-time highs. Bajaj Finance filed for a Rs 7,000 crore IPO, Kronox Lab to debut w...
- Jubilant Pharmova shares jump over 6% on receiving USFDA approval for Technetium Sulfur Colloid InjectionFor this approval, Jubilant is eligible for 180 days of exclusivity through the ‘Competitive Generic Therapy’ designation from the US FDA.
- Buy Jubilant Pharmova, target price Rs 570: Axis SecuritiesJubilant Pharmova Ltd. key Products/Revenue Segments include Organic Chemicals, Other Operating Revenue and Sale of services for the year e...
- Paytm, RVNL and 5 other stocks surpass 50-day SMAThe crossing of the 50-day SMA by these companies reflects their resilience and potential for future growth, making them noteworthy contend...
- Jubilant Pharmova shares tumble over 11% as Q4 net loss widens sequentially to Rs 98 croreJubilant Pharmova's quarterly net loss widened to INR 98 crore in the March quarter of FY23 from a loss of INR 15.67 crore in the previous ...
- Buy Jubilant Pharmova, target price Rs 475: Anand RathiJubilant Pharmova, incorporated in the year 1978, is a Mid Cap company (having a market cap of Rs 6501.86 Crore) operating in Pharmaceutica...
- Buy Jubilant Pharmova, target price Rs 417: ICICI SecuritiesJubilant Pharmova Ltd., incorporated in the year 1978, is a Mid Cap company (having a market cap of Rs 5304.06 Crore) operating in Pharmace...
- Down 50% in 1 year! What's ahead for this Rakesh Jhunjhunwala stock?Analysts have cut FY23 earning estimates by over 20 per cent. They see a near-term hangover in terms of margin and USFDA observations but s...
- Market movers: The curious case of buying and selling in BSE sharesJubilant Pharmova announced that one of its subsidiaries received Abbreviated New Drug Application (ANDA) final approval for Doxepin Hydroc...
- Why this Jhunjhunwala stock is seeing rating downgradesA few analysts believe revenues have bottomed out for drug maker Jubilant Pharmova, others do not hold high hopes in the short term
- Buy Jubilant Pharmova, target price Rs 920: Motilal OswalJubilant Pharmova Ltd., incorporated in the year 1978, is a Mid Cap company (having a market cap of Rs 11241.27 Crore) operating in Pharmac...
- Buy Jubilant Pharmova, target price Rs 960: Motilal OswalJubilant Pharmova Ltd., incorporated in the year 1978, is a Mid Cap company (having a market cap of Rs 12593.56 Crore) operating in Pharmac...
- Jubilant Pharmova surges as company develops Remdesivir oral formHospitals and pharmacists in major cities have reported acute shortage of the drug due to supply constraints and alleged hoarding.
Load More
